Q2 2025 Holdings
Filed 2025-08-14 | 21 holdings | $152.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $29.4M | 1,131,501 | 19.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $17.3M | 1,259,749 | 11.3% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $15.4M | 3,418,995 | 10.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $14.2M | 4,131,299 | 9.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $13.1M | 2,580,517 | 8.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $11.7M | 2,144,844 | 7.7% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $7.4M | 1,971,264 | 4.8% |
| Onkure Therapeutics Inc(OKUR) | CLASS A COM | 68277Q105 | $6.8M | 2,839,674 | 4.4% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $6.2M | 734,394 | 4.0% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $6.0M | 643,382 | 3.9% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.3M | 1,752,115 | 3.5% |
| Cardif Oncology Inc(CRDF) | COM | 14147L108 | $4.4M | 1,408,767 | 2.9% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $3.7M | 595,744 | 2.4% |
| Verastem Inc(VSTM) | COM | 92337C203 | $3.2M | 779,498 | 2.1% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $2.1M | 1,139,363 | 1.4% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.9M | 4,835,111 | 1.3% |
| Mural Oncology PLC | COM | G63365103 | $1.6M | 653,779 | 1.1% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.2M | 736,572 | 0.8% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $1.2M | 803,425 | 0.8% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $482.2K | 405,237 | 0.3% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $292.1K | 153,730 | 0.2% |